Call to all Biopharma Employees: Tell Your State Rep to Protect Biotech Innovation
By Bob Coughlin, President & CEO, MassBio
This week, the Massachusetts House of Representatives is set to debate a policy proposal that would allow the state to set prices for prescription drugs covered in MassHealth (the state’s Medicaid program). This proposal is the most severe and consequential piece of legislation for the Massachusetts biotech industry imaginable. If passed, it would rapidly change the face of biotech innovation, scare away investors, and immediately harm patients who are awaiting the next treatment or cure for their disease.
I’m asking anyone who works in the Massachusetts life sciences industry to take action TODAY to help prevent this from passing.
Visit MassBio’s website and fill out the form to send an email to your State Representative to tell them how they can fix this harmful proposal by supporting Amendment #1057.
All you need to enter is your home address, email, and phone. Our system does the rest. We’ve drafted an email for you to send but you should feel free to personalize it – it’s the personal stories about your work in the life sciences industry that will help your elected leaders understand why this issue is important to you.
Debate on the issue is starting as early as today – and we only have two days to act. Tell your State Rep why they should oppose this dangerous policy provision. Our industry is at stake.
Take action today: https://www.massbio.org/discover/take-action
- Bob Coughlin, President & CEO of MassBio